Electrocardiographic age acceleration was associated with significantly lower global cognitive scores in UK Biobank (β=-0.02) and Framingham (β=-0.04) cohorts.
Does ECG-derived biological age acceleration associate with lower cognitive performance in population-based cohorts?
ECG-derived biological age acceleration is significantly associated with poorer global cognitive performance, suggesting its potential as a scalable digital marker for cognitive decline risk.
Absolute Event Rate: 0% vs 0%
Abstract Background Biological age derived from 12-lead electrocardiograms (ECGs) using deep learning has emerged as a promising marker of physiological aging. However, its relationship with cognitive performance remains poorly understood. Objective To investigate the association between ECG-derived aging and cognitive performance in two large population-based cohorts. Methods We analysed data from the UK Biobank (UKB) and the Framingham Heart Study (FHS). A deep learning model estimated ECG-based biological age (ECG-age) from ECG waveforms. We calculated the difference between ECG-age and chronological age (Δage), which was used to classify participants into aging groups: accelerated aging, normal aging, and decelerated aging. Cognitive performance was measured with standardized neuropsychological tests which were grouped into six cognitive domains and a global cognitive score. Multivariable linear regression models were used to examine the associations of Δage and aging groups with cognitive performance. Results Among 59,213 UKB participants (mean age 64.7 ± 7.8 years; 51.7% women) and 6,534 FHS participants (mean age 59.5 ± 14.5 years; 55.7% women), the mean absolute error between ECG-age and chronological age was 4.7 and 7.5 years, respectively. In both cohorts, higher Δage was associated with lower global cognitive performance (UKB: β = -0.02, 95% CI: -0.03, -0.02; FHS: β = -0.04, 95% CI: -0.06, -0.02) and poorer performance across multiple cognitive domains. Conclusions ECG-derived age acceleration is associated with poorer cognitive performance across two independent cohorts. ECG-based aging metrics may serve as scalable, low-cost digital markers to identify individuals at elevated risk for cognitive decline.
Ofosuhene et al. (Tue,) reported a other. Electrocardiographic age acceleration was associated with significantly lower global cognitive scores in UK Biobank (β=-0.02) and Framingham (β=-0.04) cohorts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: